CLINICAL_TRIALS
trial_result
· 2021-06-03
Clinical Trial Update: Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690 [Phase 2]
Summary
Phase 2a study evaluating suppression of methotrexate-induced mucositis by TK112690 has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tosk, Inc. | Conditions: Mucositis | Phase 2 | Status: COMPLETED | Results posted: 2021-06-03